Cargando…

Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway

Detalles Bibliográficos
Autores principales: Li, Tian, Sun, Xiangzhou, Xu, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912637/
https://www.ncbi.nlm.nih.gov/pubmed/36759851
http://dx.doi.org/10.1186/s13578-023-00976-x
_version_ 1784885247906676736
author Li, Tian
Sun, Xiangzhou
Xu, Kewei
author_facet Li, Tian
Sun, Xiangzhou
Xu, Kewei
author_sort Li, Tian
collection PubMed
description
format Online
Article
Text
id pubmed-9912637
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99126372023-02-11 Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway Li, Tian Sun, Xiangzhou Xu, Kewei Cell Biosci Retraction Note BioMed Central 2023-02-09 /pmc/articles/PMC9912637/ /pubmed/36759851 http://dx.doi.org/10.1186/s13578-023-00976-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Li, Tian
Sun, Xiangzhou
Xu, Kewei
Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title_full Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title_fullStr Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title_full_unstemmed Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title_short Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
title_sort retraction note: the suppressing role of mir-622 in renal cell carcinoma progression by down-regulation of ccl18/mapk signal pathway
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912637/
https://www.ncbi.nlm.nih.gov/pubmed/36759851
http://dx.doi.org/10.1186/s13578-023-00976-x
work_keys_str_mv AT litian retractionnotethesuppressingroleofmir622inrenalcellcarcinomaprogressionbydownregulationofccl18mapksignalpathway
AT sunxiangzhou retractionnotethesuppressingroleofmir622inrenalcellcarcinomaprogressionbydownregulationofccl18mapksignalpathway
AT xukewei retractionnotethesuppressingroleofmir622inrenalcellcarcinomaprogressionbydownregulationofccl18mapksignalpathway